TNFSF11 and bone neoplasm: Interleukin (IL) and receptor activator of nuclear factor-kappa B ligand (RANKL), two osteolytic proteins secreted by metastatic bone cancer cells, promote osteoclast bone resorption and facilitate the secretion of immobilized growth factors from the bone matrix 12.